We interviewed Ilya Yasny, who is a luminary in the world of venture capitalism, particularly renowned for his role as a Partner at LanceBio VC, […]
Series C – Nutcracker Therapeutics
On Mar 14, 2022 Nutcracker Therapeutics closed a Series C round and raised $167,000,000 from ARCH Venture Partners, featuring lead investors ARCH Venture Partners. About […]
Series B – Medilink Therapeutics
On Mar 14, 2022 Medilink Therapeutics closed a Series B round and raised $70,000,000 from Highlight Capital, Legend Capital, Loyal Valley Capital, LYFE Capital, Qiming […]
Grant – Iaso Therapeutics
On Mar 14, 2022 Iaso Therapeutics closed a Grant round and raised $978,597 from National Science Foundation, featuring lead investors National Science Foundation. About the […]
Series C – Nutcracker Therapeutics
On Mar 14, 2022 Nutcracker Therapeutics closed a Series C round and raised $167,000,000 from ARCH Venture Partners, featuring lead investors ARCH Venture Partners. About […]
Post-IPO Equity – Freeline
On Mar 10, 2022 Freeline closed a Post-IPO Equity round and raised $26,100,000 from Syncona Partners LLP, featuring lead investors Syncona Partners LLP. About the […]
Post-IPO Equity – Puma Biotechnology
On Mar 10, 2022 Puma Biotechnology closed a Post-IPO Equity round and raised $10,000,000 from Alan H. Auerbach, Athyrium Capital Management LP, featuring lead investors […]
Series A – HelloBetter
On Mar 10, 2022 HelloBetter closed a Series A round and raised €4,000,000 from Expon Capital, HealthCap, MassMutual Ventures, Sparrow Ventures, featuring lead investors MassMutual […]
Post-IPO Equity – Freeline
On Mar 10, 2022 Freeline closed a Post-IPO Equity round and raised $26,100,000 from Syncona Partners LLP, featuring lead investors Syncona Partners LLP. About the […]
Venture Round – RefleXion Medical
On Mar 10, 2022 RefleXion Medical closed a Venture – Series Unknown round and raised $80,000,000 from Ally Bridge Group, Ascension Ventures, Catalio Capital Management, […]
